Paper
Heterocyclic benzazole derivatives with antimycobacterial in vitro activity.
Published Nov 18, 2002 · J. Kočí, V. Klimešová, K. Waisser
Bioorganic & medicinal chemistry letters
Q2 SJR score
124
Citations
0
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
In Vitro Study
Highly CitedStudy Snapshot
Heterocyclic benzazole derivatives with two nitro groups or a thioamide group show moderate antimycobacterial activity against both tuberculous and non-tuberculous mycobacteria.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Sign up to use Study Snapshot
Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.
Full text analysis coming soon...
References
Synthesis and preliminary evaluation of benzimidazole derivatives as antimicrobial agents.
The synthesized benzimidazole derivatives show significant antimycobacterial activity against non-tuberculous mycobacteria, but low antifungal activity against most yeasts.
2002·102citations·V. Klimešová et al.·European journal of medicinal chemistry
European journal of medicinal chemistry
New benzimidazole derivatives as antimycobacterial agents.
New benzimidazole derivatives show significant antimycobacterial activity, particularly against Mycobacterium kansasii, with 3,5-dinitro derivative 3t surpassing standard isoniazide against these bacteria.
2002·62citations·V. Klimešová et al.·Farmaco
Farmaco
Differentiation between inducers of apoptosis and nonspecific cytotoxic drugs by means of cell analyzer and immunoassay.
Cell analyzer and immunoassay can effectively differentiate between specific and nonspecific cytotoxic drugs, aiding in the identification of potential therapeutic targets.
2001·11citations·Dahse Hm et al.·Die Pharmazie
Die Pharmazie
Isoniazid-related copper(II) and nickel(II) complexes with antimycobacterial in vitro activity. Part 9.
Isoniazid-related copper(II) and nickel(II) complexes show in vitro antimycobacterial activity against Mycobacterium tuberculosis H37Rv, with MIC values 0.2 g/mL.
2000·90citations·B. Bottari et al.·Bioorganic & medicinal chemistry letters
Bioorganic & medicinal chemistry letters
Synthesis of 2-benzylthiopyridine-4-carbothioamide derivatives and their antimycobacterial, antifungal and photosynthesis-inhibiting activity
2-benzylthiopyridine-4-carbothioamide derivatives show antimycobacterial activity and moderate photosynthesis inhibition, with the benzylthio moiety playing a key role in these properties.
1999·44citations·V. Klimešová et al.·European Journal of Medicinal Chemistry
European Journal of Medicinal Chemistry
Synthesis and Antimicrobial Activity of New 4-(Benzylsulfanyl)pyridine Derivatives
New 4-(benzylsulfanyl)pyridine derivatives show significant antimycobacterial activity against M. tuberculosis and nontuberculous mycobacteria, but weak antifungal activities.
1999·21citations·V. Klimešová et al.·Collection of Czechoslovak Chemical Communications
Collection of Czechoslovak Chemical Communications
Potential antifungal agents. Synthesis and activity of 2-alkylthiopyridine-4-carbothioamides
2-alkylthiopyridine-4-carbothioamides show potential antifungal activity against yeasts and dermatophytes, with activity mainly related to the hydrophobicity of alkyl in position 2.
1996·33citations·V. Klimesová et al.·European Journal of Medicinal Chemistry
European Journal of Medicinal Chemistry
Research on Antifungal and Antimycobacterial Agents. Synthesis and Activity of 4‐Alkylthiopyridine‐2‐carbothioamides
Compounds 3 show good antimycobacterial activity compared to isoniazide, with moderate antifungal activity against Trichophyton mentagrophytes.
1996·16citations·V. Klimešová et al.·Archiv der Pharmazie
Archiv der Pharmazie
Citations
Recent advancements in the quest of benzazoles as anti-Mycobacterium tuberculosis agents.
Benzazole-containing compounds show potential as new anti-TB scaffolds, offering a versatile platform for new drug design and potential for creating effective and safe tuberculosis treatments.
2024·0citations·Kshitij I Patel et al.·Bioorganic chemistry
Bioorganic chemistry
KBrO3-Promoted Cross-Dehydrogenative Coupling Reaction: An Odorless Regioselective Sulfenylation of Imidazoheterocycles in Water.
The KBrO3-promoted cross-dehydrogenative coupling method in water allows for regioselective metal-free sulfenylation of imidazoheterocycles with heterocyclic thiols or thiones, offering green solvents,
2023·3citations·Xiao-Lin Cui et al.·The Journal of organic chemistry
The Journal of organic chemistry
In silico guided design of non-covalent inhibitors of DprE1: synthesis and biological evaluation
2-benzoxazolinones show potential as non-covalent inhibitors of DprE1 in XDR-TB treatment, with potential for further lead optimization and lead optimization.
2021·6citations·H. Verma et al.·SAR and QSAR in Environmental Research
SAR and QSAR in Environmental Research
Experimental and theoretical studies of 2-Mercaptobenzothiazole with 2-Bromomethylmesitylene and 1,4-Bis(bromomethyl)durene
BTM1 shows better anti-microbial activity against bacteria and fungal strains than BTD2, with potential applications in cancer treatment.
2020·7citations·Caroline Daisy et al.·Journal of Molecular Structure
Journal of Molecular Structure
Efficient novel eutectic-mixture-mediated synthesis of benzoxazole-linked pyrrolidin-2-one heterocycles
This study developed an eco-efficient strategy for synthesizing benzoxazole-linked pyrrolidinone heterocycles using a metal-free deep eutectic solvent, offering high productivity, short reaction time, and easy processing.
2020·10citations·Yassine Riadi et al.·Journal of Molecular Liquids
Journal of Molecular Liquids